Capricor Therapeutics reported $-7818000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Bluebird Bio BLUE:US $ -122.15M 10.09M
Capricor Therapeutics CAPR:US $ -7.82M 1.63M
Cytokinetics CYTK:US $ -86.75M 56.18M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Geron GERN:US $ -30.1M 1.92M
Johnson & Johnson JNJ:US $ 8218M 1879M
Newlink Genetics NLNK:US $ -7.72M 1.44M
Prothena PRTA:US $ -37.96M 4.86M
Ptc Therapeutics PTCT:US $ -121.89M 16.72M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Vascular Biogenics VBLT:US -10428000 1.32M
Vital Therapies VTL:US $ -20.81M 0.38M